Factory directly supply N-Methyl-4-Chloropyridine-2-Carboxamide - 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 22990-19-8 Assay ≥98.5% (HPLC) Solifenacin Succinate Intermediate Factory – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

To create much more benefit for consumers is our company philosophy; customer growing is our working chase for 172.612, Octreotide Acetate, 157810-81-6, We sincerely hope to determine some satisfactory interactions with you in the in the vicinity of long term. We'll hold you informed of our progress and stay up for building steady small business relations along with you.

Factory directly supply N-Methyl-4-Chloropyridine-2-Carboxamide - 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 22990-19-8 Assay ≥98.5% (HPLC) Solifenacin Succinate Intermediate Factory – Ruifu Detail:

Commercial Supply Solifenacin Succinate Related Intermediates:
Solifenacin Succinate CAS: 242478-38-2
(R)-(-)-3-Quinuclidinol CAS: 25333-42-0
(S)-(+)-3-Quinuclidinol CAS: 34583-34-1
3-Quinuclidinone Hydrochloride CAS: 1193-65-3
1-Phenyl-1,2,3,4-Tetrahydro-Isoquinoline CAS: 22990-19-8
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS: 118864-75-8

Chemical Name	1-Phenyl-1,2,3,4-Tetrahydroisoquinoline
Synonyms	1,2,3,4-Tetrahydro-1-Phenylisoquinoline
CAS Number	22990-19-8
CAT Number	RF-PI155
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H15N
Molecular Weight	209.29
Brand	Ruifu Chemical

Item	Specifications
Appearance	White Crystal Powder
Single Impurity	≤0.20%
Melting Point	93.0~99.0℃
Loss on Drying	≤0.50%
Assay	≥98.5% (HPLC)
Assay	98.5%~101.0% (on the dried basis)
Test Standard	Enterprise Standard
Usage	Solifenacin Succinate (CAS: 242478-38-2) Intermediate

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Solifenacin Succinate (CAS: 242478-38-2) is an antimuscarinic medication that is used to treat an overactive bladder causing symptoms of frequency, urgency, or incontinence. Solifenacin Succinate (CAS: 242478-38-2) is an M3 muscarinic receptor antagonist that was developed and launched for the treatment of overactive bladder (pollakiuria) in Europe. The synthesis of solifenacin involves the preparation of racemic 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline via cyclization of N-(2-phenylethyl)benzamide, and subsequent reaction with ethyl chloroformate and transesterification with (R)- 3-Quinuclidinol. Chiral chromatography affords the isolation of the desired diastereomer. Alternatively, 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline may be subjected to optical resolution with (+)-Tartaric Acid prior to treatment with ethyl chloroformate and subsequent transesterification.

Product detail pictures:

Related Product Guide:

"Sincerity, Innovation, Rigorousness, and Efficiency" is the persistent conception of our company for the long-term to develop together with customers for mutual reciprocity and mutual benefit for Factory directly supply N-Methyl-4-Chloropyridine-2-Carboxamide - 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 22990-19-8 Assay ≥98.5% (HPLC) Solifenacin Succinate Intermediate Factory – Ruifu , The product will supply to all over the world, such as: Sri Lanka, Provence, Slovakia, We are in continuous service to our growing local and international clients. We aim to be worldwide leader in this industry and with this mind; it is our great pleasure to serve and bringing the highest satisfaction rates among the growing market.